TERESA GONZALEZ: Open Payments
NPI 1639481450 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,989 in 118 payments from 16 companies in 2025. Trend: 2023 $2,592 · 2024 $2,342 · 2025 $1,989
Food & beverage: $1,989
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $548 |
| PFIZER INC. | 22 | $276 |
| Novo Nordisk Inc | 17 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $179 |
| Lilly USA, LLC | 7 | $177 |
| ABBVIE INC. | 14 | $163 |
| Otsuka America Pharmaceutical, Inc. | 7 | $135 |
| Astellas Pharma US Inc | 3 | $61 |
| Phathom Pharmaceuticals, Inc. | 6 | $53 |
| Lundbeck LLC | 2 | $39 |
Products named: AIRSUPRA, NURTEC ODT, TRINTELLIX, MOUNJARO, REXULTI, Wegovy, VRAYLAR, Ozempic.
Industry payments across AR — which companies pay providers there.
